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Our previous report indicated that magnesium (Mg) deficiency increased molybdenum (Mo) 
concentration in the rat liver, suggesting the possibility that Mg deficiency affects Mo metabolism. 
Growing male rats were given a control diet or an Mg-deficient diet for four weeks. Urine and feces 
were collected during the second and fourth weeks of the feeding trial. The liver, kidney, spleen, 
skeletal muscle, and blood were collected at the end of the feeding trial. Mg deficiency did not affect 
the apparent absorption of Mo, but it reduced urinary excretion of Mo. The retention of Mo tended to 
be higher in the Mg-deficient group than in the control group. Hepatic Mo concentration was higher 
in the Mg-deficient group than in the control group, but Mg deficiency did not affect Mo 
concentration in other tissues and plasma. Mg deficiency down-regulated the mRNA expression of 
Mo transporter 2 (MOT2) in the liver, but not in the kidney. These results suggest that Mg deficiency 
decreases urinary Mo excretion, which is too slight to affect plasma Mo concentration, and that Mg 
deficiency selectively disturbs the homeostatic mechanism of Mo in the liver, which is not related to 
the mRNA expression of MOT2 in the liver. 
 






Molybdenum (Mo) is an essential trace element in animals; however, Mo deficiency is rare in 
animals and humans, and Mo toxicity is more likely than Mo deficiency [1]. Mo toxicity is associated 
with symptoms such as growth depression, reproductive failure, diarrhea, anemia, and gout-like 
symptoms in both humans and animals [2-5]. Further, Mo toxicity induces an inflammatory response 
in the liver [6, 7]. 
Dietary Mo is efficiently absorbed in animals [8, 9] and humans [10]. The absorbed Mo is 
primarily excreted through urine; thus, urinary Mo excretion is considered to be the key pathway for 
maintaining Mo homeostasis [11]. Mo concentration was found to be relatively stable in many tissues, 
including the liver and kidney of rats, even if dietary Mo concentration was 4-fold higher than the 
nutritional requirement [12]. Another study reported that serum Mo concentration increased due to 
the dietary addition of Mo at a level 3-fold higher than the requirement in rats, but Mo concentration 
in the liver and kidney was not affected by this high level of dietary Mo [13]. Although urinary Mo 
excretion contributes to whole-body Mo homeostasis, another mechanism most likely plays a role in 
maintaining Mo homeostasis at the tissue level. 
The sole known Mo transporter in animals was recently reported as the homologue of Mo 
transporter type 2 (MOT2) of the alga Chlamydomonas reinhardtii; heterologous expression in 
Saccharomyces cerevisiae of MoT2 gene from humans indicated that this protein transported Mo into 
cells [14]. 
 Our previous study clarified that magnesium (Mg) deficiency increased Mo concentration in the 
liver of rats [15]. We hypothesized that Mg deficiency disturbs the homeostatic mechanism of Mo and 
increases hepatic Mo concentration. In the present experiment, we investigated the effect of Mg 
deficiency on the apparent absorption and urinary excretion of Mo, Mo concentration in several 
tissues, and the expression of MOT2 mRNA of the rat homologue for human MOT2 in the liver and 
kidney. 
 
Materials and Methods 
Animals and diets 
Twelve 4-week-old male Sprague-Dawley rats were purchased from SLC Japan (Shizuoka, Japan) 
and cared for according to the Guide for the Care and Use of Laboratory Animals (Animal Care 
Committee, Kyoto University). The rats were individually housed in metabolic cages fitted with urine 
and feces separators in a temperature-, humidity-, and light-controlled room (24°C, 60%, and 12-hour 
light/dark cycle, respectively). 
All rats were given the control diet, which consisted of the AIN-93G diet [16], for a 6-day 
adaptation period. The rats were then allocated to two groups of six rats each and fed either the 
control diet or the low-Mg diet. The low-Mg diet was an AIN-93G-based diet with Mg-free AIN-93G-
MX [16]. The Mg concentration was measured at 513 mg/kg and 41 mg/kg for the control and low-
Mg diets, respectively. Rats given the control diet were pair-fed to match the intake of the rats given 
the low-Mg diet for four weeks. All rats were allowed free access to demineralized water during the 
feeding trial. One of the control rats was excluded from the experiment due to severe polyuria. 
 
Sample collection 
Urinary and fecal samples were collected from days 10 to 14 (the second week) and from days 24 
to 28 (the fourth week) of the feeding trial for the determination of Mo balance. 
Under isoflurane anesthesia, blood was obtained from the abdominal aorta with a heparinized 
syringe at the end of the feeding trial. Plasma samples were separated by centrifugation at 3,000 × g 
for 30 min at 4°C. The liver, kidney, spleen, and skeletal muscle were excised promptly. 
Portions of the hepatic and renal samples were washed with ice-cold isotonic saline, placed in 
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RNA later liquid (AM7201, Applied Biosystems, USA) for 24 hours at 4°C, and then stored at -80ºC 
until mRNA analysis. The remaining liver and kidney tissues were stored at -20C until Mo analysis. 
The spleen, skeletal muscle, and plasma samples were also stored at -20C until Mo analysis. 
 
Analytical methods 
The urine, feces, tissue, and plasma samples were digested by a microwave high-pressure resolve 
device (ETHOS D, Milestone General, Japan) with trace-element-grade nitric acid (Wako Chemicals, 
Japan) and hydrogen peroxide (Wako Chemicals). The 98Mo concentration in the digested samples 
was determined by an inductively coupled plasma-mass spectrophotometer (ICP-MS, Elan 6000, 
Perkin Elmer, USA). Procedural accuracy of the Mo analysis was evaluated by spiking a rat liver 
sample with a respective standard solution; recovery for Mo was 101.8%, and the coefficient of 
variation was 1.3 %. Mg concentration in digested plasma was determined by an atomic absorption 
spectrophotometer (AA-6600F, Shimadzu, Kyoto, Japan). Creatinine concentration in plasma and 
urine was determined by the Jaffé method [17]. 
 Total RNA was extracted from hepatic and renal samples with TRIzol reagents (Invitrogen, USA) 
according to the manufacturer's protocol. The wavelength ratio at 260 and 280 nm was measured for 
quantitative analysis of the isolated RNA. Total RNA was reverse transcribed with random primers 
(ABI high-capacity cDNA reverse transcription kit, Applied Biosystems, USA). Aliquots of the 
cDNA were used as a template for the following quantitative PCR using a Real-Time PCR System 
(Rotor-Gene 6000, Corbett Research, Australia). The gene transcripts of MOT2 and -actin were 
amplified using the SYBR Premix Ex Taq II (TaKaRa Bio, Japan) as described previously [18]. 
The gene product of MFSD5 (major facilitator superfamily domain containing 5) was identified as 
MOT2 in humans (GenBank accession no. BAC11137) [14]. Although the activity of MOT2 as an 
Mo transporter is not determined in rats, the rat homologue of human MFSD 5 has been recorded 
(GenBank accession no. NM_001126282). The following PCR primer set was used: forward, 5’- 
TGACTTCCCTGCCGAGTG-3’ and reverse, 5’-CCAGCACATGGTTCCAGA-3’ for the rat MOT2 
(NM_001126282); and forward, 5’-ACCCGCGAGTACAACCTTCT-3’ and reverse, 5’-
TCGTCATCCATGGCGAACTG-3’ for the rat -actin (GenBank accession number: NM_031144.2). 
The relative levels of MOT2 mRNA expression were normalized against the mRNA level of -actin 
and represented as a ratio of the MOT2 mRNA level in the control group for each tissue type. 
 
Calculation and Statistical analysis 
Apparent absorption and retention of Mo were calculated in the second and fourth weeks of the 
feeding trial as follows: 
Apparent absorption of Mo (μg/day) = Mo intake (μg/day) – Fecal Mo excretion (μg/day); 
Retention of Mo (μg/day) = Apparent absorption of Mo (μg/day) – Urinary Mo excretion (μg/day).  
The glomerular filtration rate (GFR) was approximated by creatinine clearance [19]. The GFR, Mo 
filtration at the glomerulus, and Mo reabsorption were calculated in the fourth week as follows: 
GFR (mL/day) = [Urinary creatinine excretion (mg/day)] / Plasma creatinine concentration 
(mg/mL); Mo filtration (g/day) = GFR (mL/day) × Plasma Mo concentration (g/mL); Mo 
reabsorption (g/day) = Mo filtration (g/day) - Urinary Mo excretion (g/day); Fractional 
reabsorption of Mo (%) = [Mo reabsorption (g/day) / Mo filtration (g/day)] × 100. 
Data were expressed as the mean and standard error of the mean (SEM). The Mo balance data 
were analyzed with a repeated ANOVA with the statistical model consisting of the effect of treatment 
(Mg deficiency and control), the effect of period (the second week and the fourth week) and their 
interaction. All remaining data were analyzed using a one-way ANOVA. The statistical analyses were 





Symptom of magnesium deficiency 
Plasma Mg concentration was 23.0 and 8.8 (SEM, 2.3) mg/L in the control diet and low-Mg diet 
groups, respectively, and a significant effect of the dietary treatment was observed (P < 0.001). 
Beginning 3 days after the initiation of dietary treatment, all of the rats fed the low-Mg diet 
presented with skin lesions on the ears and tail, a typical sign of Mg deficiency. However, no skin 
lesions were observed in rats given the control diet during the feeding trial (data not shown). These 
results indicate that the rats given the low-Mg diet suffered from Mg deficiency in the present 
experiment.  
 
Molybdenum concentration in the tissues and plasma  
The Mg-deficient group had a higher (P = 0.033) hepatic Mo concentration than the control group 
(Table 1). On the other hand, the dietary treatment did not affect Mo concentration in the other tissues. 
The plasma Mo concentrations were similar in both groups. 
 
Molybdenum balance 
We determined Mo balance in the second and the fourth weeks of the feeding trial (Table 2). 
Dietary treatment did not affect Mo intake because the animals were pair-fed. The duration of the 
experiment significantly affected Mo intake (P = 0.019). The apparent absorption of Mo was not 
affected by the treatment, and a significant interaction was not observed. Thus, Mg deficiency did not 
affect the apparent absorption of Mo during each period. Urinary excretion of Mo was affected by the 
treatment (P = 0.005), but a significant interaction was not observed. These results indicate that Mg 
deficiency decreased urinary Mo excretion, irrespective of the collection period. The retention of Mo 
tended to increase as a result of treatment (P = 0.077), but no significant interaction was noted. 
 
Renal handling of molybdenum 
Plasma creatinine concentration was 4.26 and 4.50 (SEM 0.15) mg/L in the control and Mg-
deficient groups, respectively, and the effect of treatment was not significant. GFR was significantly 
lower (P = 0.002) in the Mg-deficient group than in the control group (Table 3). The Mo filtration at 
the glomerulus was also lower (P = 0.021) in the Mg-deficient group than in the control group. The 
fractional reabsorption of Mo was not affected by the dietary treatment; thus, the amount of Mo 
reabsorption was significantly lower (P = 0.023) in the Mg-deficient group than in the control group 
because Mo filtration was lower for the Mg-deficient group. As a result, Mg deficiency decreased 
urinary Mo excretion by decreasing GFR without increasing the efficiency of Mo reabsorption. 
 
Expression of MOT2 mRNA 
We determined the expression of MOT2 mRNA in the liver and kidney. Mg deficiency down-
regulated mRNA expression of MOT2 in the liver (P = 0.036) but did not affect its expression in the 
kidney (Fig. 1). 
  
Discussion 
The present experiment clarifies that: 1) Mg deficiency decreased urinary Mo excretion by 
decreasing GFR, and the reduction of urinary Mo excretion slightly affected Mo retention (Table 2, 
3); 2) Mg deficiency increased Mo concentration in the liver but not in other tissues and plasma 
(Table 1); and 3) Mg deficiency down-regulated mRNA expression of MOT2 (Fig. 1), which is the 
only known Mo transporter in animals and is responsible for cellular Mo uptake [14]. These results 
suggest that Mg deficiency selectively increases hepatic Mo concentration by an unknown 
mechanism. 
Mg deficiency has been reported to affect other mineral concentrations in various tissues and 
plasma [20-23]. Our previous study indicated that Mg deficiency increased hepatic Mo concentration 
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in rats [15], which was confirmed by the present experiment (Table 1). Therefore, we hypothesized 
that Mg deficiency disturbs the homeostatic mechanism of Mo. 
We investigated the effect of Mg deficiency on Mo balance and renal handling of Mo. The 
duration of the experiment significantly increased Mo intake because feed intake increased with 
growth in the Mg-deficient group (Table 2). Mg deficiency did not affect the apparent absorption of 
Mo (Table 2). However, Mg deficiency decreased GFR (Table 3), which was supported by a report 
using inulin clearance for assessing GFR in rats [24], resulting in the reduction of urinary Mo 
excretion in the present study (Table 2). Because urinary Mo excretion is considered to be the key 
pathway for maintaining Mo homeostasis [11], Mo retention is probably affected by urinary Mo 
excretion. We consider that the decrease in urinary excretion of Mo increased Mo retention in Mg 
deficient rats, although the effect of dietary treatment on Mo retention was not significant in the 
present study. Mo is efficiently absorbed, and plasma or serum Mo concentration readily increases 
with an elevated Mo intake in humans [25] and in rats [13]. It must be noted that Mg deficiency did 
not affect plasma Mo concentration, which suggests that the increase in Mo retention is too slight to 
increase plasma Mo concentration. 
Mg deficiency increased hepatic Mo concentration but did not affect Mo concentration in the other 
tissues (Table 1). These results indicate that Mg deficiency selectively increases hepatic Mo 
concentration. Jimenez et al. [14] identified an Mo transporter in humans, MOT2, which is also the 
sole Mo transporter discovered in animals. MOT2 transports Mo into cells and MOT2 mRNA is 
expressed in a number of tissues, including the liver. The present experiment showed that the 
expression of MOT2 mRNA was down-regulated, not up-regulated, by Mg deficiency in the liver (Fig. 
1). Therefore, the increase in hepatic Mo concentration is unlikely to result from the increase in Mo 
uptake by up-regulating MOT2 expression. The expression of MOT2 is transcriptionally up-regulated 
after Mo shortage in the alga [14]. We can speculate that the expression of MOT2 mRNA is also 
regulated by Mo status in the liver; the increase in hepatic Mo concentration suppresses MOT2 
mRNA expression, which plays a role in maintaining Mo homeostasis in the liver. 
In conclusion, Mg deficiency selectively disturbs the homeostatic mechanism of Mo in the liver. 
Further studies are necessary for clarifying how Mg deficiency increases hepatic Mo concentration. 
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Table 1. Effect of Mg deficiency on Mo concentrations in several tissues and plasma of rats 
 Control Mg deficiency SEMa P value 
Liver, μg/kg 434 531 24  0.033  
Kidney, μg/kg 291 282 7  0.546  
Spleen, μg/kg 84 98 5  0.167  
Skeletal muscle, μg/kg 18 27 3  0.114  
Plasma, μg/L 30 29 2  0.956  
Values are means. 
aSEM: Standard error of mean (Control: n=5; Mg deficiency: n=6) 
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Table 2. Effect of Mg deficiency on Mo balance in rats 
 



















Intake 2.76 2.85 2.96 2.96 0.03 0.514 0.019 0.431 
Apparent absorption 2.17 2.01 2.51 2.42 0.06 0.211 0.003 0.726 
Urinary excretion 2.36 1.75 2.77 2.43 0.11 0.005 0.018 0.497 
Retention -0.19 0.26 -0.26 -0.01 0.09 0.077 0.361 0.590 
Values are means. 
aSEM: Standard error of mean (Control: n=5; Mg deficiency: n=6) 




Table 3. Effect of Mg deficiency on renal handling of Mo in rats 
 Control Mg deficiency SEMa P value 
GFRb, mL/day 1,574 1,148 81 0.002  
Mo filtration, g/day 46.6 32.8 3.2 0.021  
Mo reabsorption, g/day 43.8 30.4 3.1 0.023  
Fractional reabsorption of Mo, % 93.8 92.5 0.5 0.238  
Values are means. 
aSEM, Standard error of mean (Control, n = 5; Mg deficiency, n = 6) 




Figure 1. Effect of Mg deficiency on MOT2 mRNA expression in the liver and kidney. Data are 
expressed as a value relative to the control group, and error bars indicate the SEM. Closed and 
hatched columns indicate results for the control (n=5) and Mg-deficient groups (n=6), respectively. 
